Ami Fadia Stock Analyst Profile - Needham Research Coverage - Stocknear

Ami Fadia

Stock Analyst at Needham

(5)
# 446
Out of 5,470 analysts
512
Total ratings
Success rate
Average return
39 Stocks
Name Action PT Current % Upside Ratings Updated
BIIB Biogen
Reiterates: Hold
n/a
n/a n/a 42 Sep 4, 2025
JAZZ Jazz Pharmaceuticals
Reiterates: Buy
202 202
129.85 55.56% 34 Aug 28, 2025
IMRX Immuneering
Reiterates: Buy
8 8
5.95 34.45% 18 Aug 26, 2025
RVMD Revolution Medicines
Maintains: Buy
57 56
41.06 36.39% 25 Aug 7, 2025
MRUS Merus
Maintains: Buy
97 96
67.19 42.88% 30 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 16
7.47 114.19% 21 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
150 150
129.29 16.02% 16 Aug 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
45 45
28.45 58.17% 3 Jul 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30 30
25.39 18.16% 10 Jun 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 23 Jun 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 22 Jun 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
80 80
40.75 96.32% 12 Jun 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
130 130
129.46 0.42% 31 Jun 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
18.03 94.12% 1 May 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
1.66 201.2% 9 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
19 19
15.38 23.54% 36 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
49 49
35.83 36.76% 37 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
138 139
143.8 -3.34% 14 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
29 29
7 314.29% 20 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 27 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 6 Jul 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 7 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
n/a
n/a n/a 1 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
40
14.7 172.11% 1 Feb 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
28 26
26.98 -3.63% 6 Feb 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
240 320
14.78 2065.09% 2 Feb 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
63 75
26.74 180.48% 7 Jan 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
4 5
n/a n/a 2 Jan 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
10 14
n/a n/a 3 Oct 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
15 23
0.66 3309.09% 4 Oct 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
64 63
22.33 182.13% 4 Sep 17, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
2 2
n/a n/a 8 Sep 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
8 10
n/a n/a 2 Jul 10, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
24
n/a n/a 8 Jan 27, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
9 20
n/a n/a 2 Sep 17, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
12 5
5.58 -10.39% 2 Jan 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Market Perform
n/a
n/a n/a 7 Oct 1, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
12
n/a n/a 5 Jan 3, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
22
1.3 1592.31% 4 Jan 3, 2018